|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Additional conditions recognized in this trial | ||||
| Deficiency Diseases | |||||
| Ornithine Carbamoyltransferase Deficiency Disease | |||||
| 2 | More general conditions related to this trial | ||||
| Amino Acid Metabolism, Inborn Errors | |||||
| Brain Diseases | |||||
| Brain Diseases, Metabolic | |||||
| Brain Diseases, Metabolic, Inborn | |||||
| Central Nervous System Diseases | |||||
| Genetic Diseases, Inborn | |||||
| Malnutrition | |||||
| Metabolic Diseases | |||||
| Metabolism, Inborn Errors | |||||
| Nervous System Diseases | |||||
| Nutrition Disorders | |||||
| 3 | Sponsors listed in this trial | ||||
| FDA Office of Orphan Products Development | |||||
| University of Pennsylvania | |||||